Does “wearing off” of efficacy occur in galcanezumab‐treated patients at the end of the monthly treatment cycle? Post hoc analyses of four phase III randomized trials

OBJECTIVE: The purpose of this study was to propose a definition of “wearing off” at the individual patient‐level and determine the percentage of patients with migraine who experience “wearing off” of efficacy of galcanezumab at the end of a treatment cycle using this predefined threshold. BACKGROUN...

Descripción completa

Detalles Bibliográficos
Autores principales: Ailani, Jessica, Kuruppu, Dulanji K., Rettiganti, Mallikarjuna, Oakes, Tina, Schroeder, Krista, Wietecha, Linda, Port, Martha, Blumenfeld, Andrew M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Submissions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306502/
https://www.ncbi.nlm.nih.gov/pubmed/35076090
http://dx.doi.org/10.1111/head.14257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306502/
https://www.ncbi.nlm.nih.gov/pubmed/35076090
http://dx.doi.org/10.1111/head.14257

Ejemplares similares